October 02, 2025

Bridging the Gap in Geriatric Oncology Education: A Global Imperative

As the global population ages, oncology faces an urgent challenge: ensuring that health-care professionals are adequately trained to address the unique complexities of cancer care for older adults. De...

The ASCO Post

October 02, 2025

Medical Oddities: Early Embryos Made From Skin Cells?

Science serves up embryos, lattes, flu flavors, and a crash course in kids’ safety.

Conexiant

October 02, 2025

Two Eyes, One Day

Will ISBCS eventually become the new global “norm” for bilateral cataract patients?

The Ophthalmologist

October 02, 2025

Brookdale Department of Geriatrics and Palliative Medicine at the Forefront of Innovative Fellowship Programs

The Brookdale Department has created flexible programs allowing doctors to pursue training in their chosen specialties, while also providing opportunities for professional development in geriatrics and palliative medicine.

Mount Sinai New York

October 02, 2025

Specialty Reports September 2025

Mount Sinai Health System is pleased to present these reports covering our groundbreaking research and compassionate, equitable, and safe patient care.

Mount Sinai New York

October 01, 2025

Shutdown Showdown: How Long Can Health Services Last?

Federal shutdown suspends some health services, limits National Institutes of Health research, and raises questions about Affordable Care Act subsidies, Medicaid, and public health programs.

KFF Health News

October 01, 2025

Thriving in Times of Change

Navigating the Growth of the DSO Model and Consolidation of the Dental Lab Industry

Inside Dental Technology

October 01, 2025

Beyond CPAP: Exploring Alternative Therapies for Sleep Apnea Management

An 83-year-old Air Force veteran and longtime Miami resident was diagnosed with obstructive sleep apnea (OSA), a condition that caused him to stop breathing dozens of times every hour as he slept.

Baptist Health South Florida

October 01, 2025

AI Speeds Search for Therapies That Fight Adenocarcinoma

Mount Sinai researchers are assessing a platform that can conduct in silico scans of millions of potential drugs each day to identify candidates for testing and validation. The goal is to facilitate the identification of safe, effective therapeutics for patients with invasive early-stage lung adenocarcinoma.

Mount Sinai New York